The wound care market is expected to reach USD 22.81 billion by 2023 from USD 18.99 billion in 2018 at a CAGR of 3.7%. The base year for this study is 2017 and the forecast period includes 2018-2023.
Developments and innovations in wound care products drives the global wound care market
The development of new products is another major factor driving the growth of the wound care market. The continuous development of new products provides end users with advanced options for wound treatment (especially in the case of hard-to-heal wounds). Several companies such as Organogenesis (US), and Smith & Nephew plc. (UK) are investing heavily in R&D to develop new and advanced products.
Rising prevalence of chronic wounds drives the growth of wound care market
Diabetic foot ulcers (DFUs)
Diabetic foot ulcers are a serious complication of diabetes and often lead to deformities of the lower extremity or amputation of the leg. Foot ulcers usually occur when there is nerve damage (termed neuropathy). As the nerves are affected, the patient’s ability to feel pain, heat, and cold is reduced, resulting in ulcer formation. Apart from nerve damage, Charcot neuropathic osteoarthropathy (CN) is a primary risk factor. This affects the bones, joints, foot, ankles, and soft tissues in the early phase.
PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=371
Pressure Ulcers
A pressure ulcer is an area of damage to the skin and underlying tissue that is caused by unrelieved pressure, friction, and/or shear forces. A severe ulcer is susceptible to infection and may be life-threatening. The costs associated with pressure ulcers are considerable. According to the Agency for Healthcare Research & Quality (AHRQ), pressure ulcers cost the US healthcare system an estimated USD 9.10–USD 11.60 billion each year. The cost of treating a pressure ulcer depends on its severity, with estimates generally ranging from USD 2,000–USD 20,000 per ulcer.
Venous Leg Ulcers
Leg ulceration is commonly caused by venous hypertension resulting from valvular incompetence in superficial, deep, or perforating veins. Sustained venous hypertension causes swelling, restricted blood flow, and damage to the skin and other tissues. Venous disease (~80%) and arterial disease (~15%) are two of the major causes of venous leg ulcers. The incidence of leg ulcers is increasing as a result of the rising geriatric population and growing risk factors for atherosclerotic occlusion due to smoking, obesity, and diabetes. The growing incidence of leg ulcers will subsequently drive the market for wound care products used for their treatment.
Major players in the wound care market include Smith & Nephew plc. (UK); Acelity L.P. Inc. (US); ConvaTec Group Plc. (UK); 3M Company (US); Ethicon (US); Mölnlycke Health Care AB (Sweden); Covidien plc (Ireland); Coloplast A/S (Ireland); Baxter International Inc. (US); Derma Sciences, Inc. (US); and Hollister Incorporated (US).
More Info: https://www.marketsandmarkets.com/Market-Reports/wound-care-market-371.html
